Ewout M Baerveldt Selected Research

Ustekinumab (CNTO 1275)

4/2013

Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ewout M Baerveldt Research Topics

Disease

5	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2015 - 03/2010
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2019
1	Sepsis (Septicemia) 09/2013
1	Behcet Syndrome (Behcet's Syndrome) 04/2013
1	Hidradenitis Suppurativa 04/2013
1	Dermatitis 01/2011

Drug/Important Bio-Agent (IBA)

3	Interleukin-4 (Interleukin 4)IBA 08/2015 - 01/2011
1	HhAntag691IBA 03/2019
1	Interleukin-23 (Interleukin 23)IBA 08/2015
1	CytokinesIBA 08/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2013
1	Ustekinumab (CNTO 1275)FDA Link 04/2013
1	Vitamin D FDA LinkGeneric 07/2011
1	GlucocorticoidsIBA 07/2011
1	RNA (Ribonucleic Acid)IBA 07/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2011
1	Imiquimod (Aldara)FDA LinkGeneric 01/2011
1	Interleukin-23 Subunit p19IBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010

Therapy/Procedure

2	Therapeutics 07/2011 - 03/2010
1	Phototherapy (Light Therapy) 07/2011
1	Dye Lasers 03/2010